Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MRI-Guided Laser Ablation for Pediatric Brain Tumors
NCT02372409Phase 2Terminated
- Sponsor
- Washington University School of Medicine
- Start
- Aug 2015
- Primary completion
- Mar 2023
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Phase 2, open-label trial of doxorubicin and etoposide in glioma (2 arms), sponsored by Washington University School of Medicine. Primary endpoints: Progression-free Survival at 6 months and Overall Survival at 5 years. Started Aug 2015; status: terminated.
02
Drugs
doxorubicinetoposide
03
Conditions
glioma
Beyond the preview
Go deeper on NCT02372409.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02372409.